Cortical Spheroid Model for Studying the Effects of Ischemic Brain Injury

Overview

Journal In Vitro Model

Date 2025 Jan 28

PMID 39872876

Authors

Rachel M McLaughlin

Ilayda Top

Amanda Laguna

Christien Hernandez

Harrison Katz

Liane L Livi

Liana Kramer

Samantha G Zambuto

Diane Hoffman-Kim

Affiliations

Soon will be listed here.

Abstract

Purpose: Ischemic brain injury occurs when there is reduced or complete disruption of blood flow to a brain region, such as in stroke or severe traumatic brain injury. Even short interruptions can lead to devastating effects including excitotoxicity and widespread cell death. Despite many decades of research, there are still very few therapeutic options for patients suffering from brain ischemia.

Methods: We developed an in vitro brain ischemia model using our previously established 3D spheroids derived from primary postnatal rat cortex. These spheroids provide an in vivo-relevant model containing a similar cellular composition to the native cortex and a cell-synthesized extracellular matrix. This model is cost-effective, highly reproducible, and can be produced in a high-throughput manner, making it an ideal candidate for screening potential therapeutics. To study the cellular and molecular mechanisms of stroke in this model, spheroids were deprived of glucose, oxygen, or both oxygen and glucose for 24 h.

Results: Both oxygen and oxygen-glucose deprived spheroids demonstrated many of the hallmarks of ischemic brain injury, including a decrease in metabolism, an increase in neural dysfunction, breakdown in the neurovascular unit, and an increase in reactive astrocytes. Pretreatment of spheroids with the antioxidant agent N-acetylcysteine (NAC) mitigated the decrease in ATP after oxygen-glucose deprivation, was partially neuroprotective, and enhanced the expression of laminin.

Conclusion: This 3D cortical spheroid model provides a platform for studying ischemic injury and has the potential for screening therapeutics.

Supplementary Information: The online version contains supplementary material available at 10.1007/s44164-023-00046-z.

References

Dingle Y, Boutin M, Chirila A, Livi L, Labriola N, Jakubek L . Three-Dimensional Neural Spheroid Culture: An In Vitro Model for Cortical Studies. Tissue Eng Part C Methods. 2015; 21(12):1274-83. PMC: 4663656. DOI: 10.1089/ten.TEC.2015.0135. View

Hind W, England T, OSullivan S . Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARγ and 5-HT1A receptors. Br J Pharmacol. 2015; 173(5):815-25. PMC: 4761095. DOI: 10.1111/bph.13368. View

Jensen C, Teng Y . Is It Time to Start Transitioning From 2D to 3D Cell Culture?. Front Mol Biosci. 2020; 7:33. PMC: 7067892. DOI: 10.3389/fmolb.2020.00033. View

Jiang M, Zhao Y, Cao W, Wei Z, Gu X, Wei L . Long-term survival and regeneration of neuronal and vasculature cells inside the core region after ischemic stroke in adult mice. Brain Pathol. 2016; 27(4):480-498. PMC: 5303567. DOI: 10.1111/bpa.12425. View

Sekhon B, Sekhon C, Khan M, Patel S, Singh I, Singh A . N-Acetyl cysteine protects against injury in a rat model of focal cerebral ischemia. Brain Res. 2003; 971(1):1-8. DOI: 10.1016/s0006-8993(03)02244-3. View

Jiang X, Andjelkovic A, Zhu L, Yang T, Bennett M, Chen J . Blood-brain barrier dysfunction and recovery after ischemic stroke. Prog Neurobiol. 2017; 163-164:144-171. PMC: 5886838. DOI: 10.1016/j.pneurobio.2017.10.001. View

Karp N, Reavey N . Sex bias in preclinical research and an exploration of how to change the status quo. Br J Pharmacol. 2018; 176(21):4107-4118. PMC: 6877896. DOI: 10.1111/bph.14539. View

Kharlamov A, LaVerde G, Nemoto E, Jungreis C, Yushmanov V, Jones S . MAP2 immunostaining in thick sections for early ischemic stroke infarct volume in non-human primate brain. J Neurosci Methods. 2009; 182(2):205-10. PMC: 2774726. DOI: 10.1016/j.jneumeth.2009.06.014. View

Ramirez F, Motazedian P, Jung R, Di Santo P, Macdonald Z, Simard T . Sex Bias Is Increasingly Prevalent in Preclinical Cardiovascular Research: Implications for Translational Medicine and Health Equity for Women: A Systematic Assessment of Leading Cardiovascular Journals Over a 10-Year Period. Circulation. 2017; 135(6):625-626. DOI: 10.1161/CIRCULATIONAHA.116.026668. View

10.

Mergenthaler P, Meisel A . Do stroke models model stroke?. Dis Model Mech. 2012; 5(6):718-25. PMC: 3484854. DOI: 10.1242/dmm.010033. View

11.

Lee Y, Lee S . Neuroprotective effects of N-acetylcysteine via inhibition of matrix metalloproteinase in a mouse model of transient global cerebral ischemia. Brain Res Bull. 2019; 154:142-150. DOI: 10.1016/j.brainresbull.2019.10.004. View

12.

Bhalerao A, Sivandzade F, Archie S, Chowdhury E, Noorani B, Cucullo L . In vitro modeling of the neurovascular unit: advances in the field. Fluids Barriers CNS. 2020; 17(1):22. PMC: 7077137. DOI: 10.1186/s12987-020-00183-7. View

13.

Boutin M, Kramer L, Livi L, Brown T, Moore C, Hoffman-Kim D . A three-dimensional neural spheroid model for capillary-like network formation. J Neurosci Methods. 2017; 299:55-63. DOI: 10.1016/j.jneumeth.2017.01.014. View

14.

Zhang W, Wang X, Narayanan M, Zhang Y, Huo C, Reed J . Fundamental role of the Rip2/caspase-1 pathway in hypoxia and ischemia-induced neuronal cell death. Proc Natl Acad Sci U S A. 2003; 100(26):16012-7. PMC: 307684. DOI: 10.1073/pnas.2534856100. View

15.

Turkmen S, Cekic Gonenc O, Karaca Y, Mentese A, Demir S, Beyhun E . The effect of ethyl pyruvate and N-acetylcysteine on ischemia-reperfusion injury in an experimental model of ischemic stroke. Am J Emerg Med. 2016; 34(9):1804-7. DOI: 10.1016/j.ajem.2016.06.003. View

16.

Kalaria R . The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging. 2000; 21(2):321-30. DOI: 10.1016/s0197-4580(00)00125-1. View

17.

Beery A, Zucker I . Sex bias in neuroscience and biomedical research. Neurosci Biobehav Rev. 2010; 35(3):565-72. PMC: 3008499. DOI: 10.1016/j.neubiorev.2010.07.002. View

18.

Zhang Z, Yan J, Taheri S, Liu K, Shi H . Hypoxia-inducible factor 1 contributes to N-acetylcysteine's protection in stroke. Free Radic Biol Med. 2013; 68:8-21. PMC: 3943875. DOI: 10.1016/j.freeradbiomed.2013.11.007. View

19.

Guney O, Erdi F, Esen H, Kiyici A, Kocaogullar Y . N-acetylcysteine prevents vasospasm after subarachnoid hemorrhage. World Neurosurg. 2010; 73(1):42-9. DOI: 10.1016/j.surneu.2009.06.003. View

20.

Van Breedam E, Ponsaerts P . Promising Strategies for the Development of Advanced In Vitro Models with High Predictive Power in Ischaemic Stroke Research. Int J Mol Sci. 2022; 23(13). PMC: 9266337. DOI: 10.3390/ijms23137140. View